Zhikai Zheng

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0003-4587-2665

发表论文 8 篇 · 总被引 26 次 · h-index 3

代表论文

Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study (2024 · International Journal of Surgery · 被引 9)
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy (2024 · Journal of Hepatocellular Carcinoma · 被引 6)
Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy (2023 · Journal of Hepatocellular Carcinoma · 被引 3)
Anti-programmed Cell Death Protein-1 Therapy in Intrahepatic Cholangiocarcinoma Induced Type 1 Diabetes: A Case Report and Literature Review (2022 · Frontiers in Public Health · 被引 3)
[Analysis of the efficacy and safety of hepatic arterial infusion chemotherapy for unresectable hepatitis B-related intrahepatic cholangiocarcinoma]. (2024 · PubMed · 被引 2)
Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy (2023 · Journal of Hepatocellular Carcinoma · 被引 2)